SARS-CoV-2-IN-107
Product Specifications
Target
SARS-CoV|||Virus Protease|||NO Synthase
Related Pathways
Microbiology/Virology|||Immunology/Inflammation
Bioactivity
SARS-CoV-2-IN-107 (Compound A7) is an inhibitor of SARS-CoV-2 3CLpro, with an IC50 of 261.3 nM. It inhibits the replication of SARS-CoV-2, exhibiting an EC50 of 11.7 ?M. Additionally, SARS-CoV-2-IN-107 demonstrates anti-inflammatory activity in LPS-stimulated RAW264.7 macrophages, with a NO inhibition rate of 68.6%.
Smiles
C1=CC(=CC=C1C(=O)/C=C/C2=CC(=C(C(=C2)O)O)O)F
Molecular Formula
C15H11FO4
Molecular Weight
274.244
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
C2262-51H 1 mL
CD11b (CD11 Antigen-like Family Member B, Cell Surface Glycoprotein MAC-1 Subunit alpha, CR-3 alpha Chain, CR3A, Integrin alpha-M, ITGAM, Leukocyte Adhesion Receptor MO1, MAC-1, MAC1A, MGC117044, MO1A, Neutrophil Adherence Receptor, SLEB6) discontinued
Ask
View Details